Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Anypodetos
m (Bypass redirs)
blackwiki>Ronhjones
(use listclass = hlist in navbox as per WP:HLIST)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
 
| name  = Antithrombotics
 
| name  = Antithrombotics
| title = [[Antithrombotic]]s ([[thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
+
| title = [[Antithrombotic]]s ([[thrombolytic drug|thrombolytics]]
 +
|listclass = hlist
 +
* [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
 
| groupstyle = background:MistyRose;  
 
| groupstyle = background:MistyRose;  
  
Line 9: Line 11:
  
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
 
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
|  list1 = [[Abciximab]] • [[Eptifibatide]] • [[Tirofiban]]
+
|  list1 =
 +
* [[Abciximab]]
 +
* [[Eptifibatide]]
 +
* [[Tirofiban]]
  
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
|  list2 = ''[[thienopyridine]]s'' ([[Clopidogrel]], [[Prasugrel]], [[Ticlopidine]])&nbsp;• ''[[nucleotide]]/[[nucleoside]] analogs'' ([[Cangrelor]], [[Elinogrel]], [[Ticagrelor]])
+
|  list2 =
 +
* ''[[thienopyridine]]s'' ([[Clopidogrel]]
 +
* [[Prasugrel]]
 +
* [[Ticlopidine]])
 +
* ''[[nucleotide]]/[[nucleoside]] analogs'' ([[Cangrelor]]
 +
* [[Elinogrel]]
 +
* [[Ticagrelor]])
  
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
 
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
|  list3 = [[Beraprost]]&nbsp;• [[Prostacyclin]]&nbsp;• [[Iloprost]]&nbsp;• [[Treprostinil]]
+
|  list3 =
 +
* [[Beraprost]]
 +
* [[Prostacyclin]]
 +
* [[Iloprost]]
 +
* [[Treprostinil]]
  
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
 
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
|  list4 = [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>&nbsp;• [[Aloxiprin]]&nbsp;• [[Carbasalate calcium]]&nbsp;• [[Indobufen]]&nbsp;• [[Triflusal]]
+
|  list4 =
 +
* [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>
 +
* [[Aloxiprin]]
 +
* [[Carbasalate calcium]]
 +
* [[Indobufen]]
 +
* [[Triflusal]]
  
 
| group5 = [[Thromboxane inhibitors]]
 
| group5 = [[Thromboxane inhibitors]]
|  list5 = ''[[thromboxane synthase inhibitors]]'' ([[Dipyridamole]], [[Picotamide]])&nbsp;• ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
+
|  list5 =
 +
* ''[[thromboxane synthase inhibitors]]'' ([[Dipyridamole]]
 +
* [[Picotamide]])
 +
* ''[[Thromboxane receptor antagonist|receptor antagonist]]'' ([[Terutroban]]<sup>†</sup>)
  
 
| group6 = [[Phosphodiesterase inhibitor]]s
 
| group6 = [[Phosphodiesterase inhibitor]]s
|  list6 = [[Cilostazol]]&nbsp;• [[Dipyridamole]]&nbsp;• [[Triflusal]]
+
|  list6 =
 +
* [[Cilostazol]]
 +
* [[Dipyridamole]]
 +
* [[Triflusal]]
  
 
| group7 = Other  
 
| group7 = Other  
|  list7 = [[Cloricromen]]&nbsp;• [[Ditazole]]
+
|  list7 =
 +
* [[Cloricromen]]
 +
* [[Ditazole]]
  
 
}}
 
}}
Line 35: Line 63:
 
   | groupstyle = background-color: MistyRose
 
   | groupstyle = background-color: MistyRose
  
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
+
   | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
   |  list1 = ''[[coumarin]]s:'' [[Acenocoumarol]]&nbsp;• [[Coumatetralyl]]&nbsp;• [[Dicoumarol]]&nbsp;• [[Ethyl biscoumacetate]]&nbsp;• [[Phenprocoumon]]&nbsp;• [[Warfarin]]<sup>#</sup>
+
   |  list1 =
 +
* ''[[coumarin]]s:'' [[Acenocoumarol]]
 +
* [[Coumatetralyl]]
 +
* [[Dicoumarol]]
 +
* [[Ethyl biscoumacetate]]
 +
* [[Phenprocoumon]]
 +
* [[Warfarin]]<sup>#</sup>
  
''[[1,3-Indandione]]s:'' [[Clorindione]]&nbsp;• [[Diphenadione]]&nbsp;• [[Phenindione]]
+
*''[[1,3-Indandione]]s:'' [[Clorindione]]
 +
* [[Diphenadione]]
 +
* [[Phenindione]]
  
 
''other:'' [[Tioclomarol]]  
 
''other:'' [[Tioclomarol]]  
Line 47: Line 83:
  
 
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
 
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
| list1  = ''[[low-molecular-weight heparin]]'' ([[Bemiparin sodium|Bemiparin]], [[Certoparin sodium|Certoparin]], [[Dalteparin sodium|Dalteparin]], [[Enoxaparin sodium|Enoxaparin]], [[Nadroparin calcium|Nadroparin]], [[Parnaparin sodium|Parnaparin]], [[Reviparin sodium|Reviparin]], [[Tinzaparin sodium|Tinzaparin]])
+
| list1  =
 +
* ''[[low-molecular-weight heparin]]'' ([[Bemiparin sodium|Bemiparin]]
 +
* [[Certoparin sodium|Certoparin]]
 +
* [[Dalteparin sodium|Dalteparin]]
 +
* [[Enoxaparin sodium|Enoxaparin]]
 +
* [[Nadroparin calcium|Nadroparin]]
 +
* [[Parnaparin sodium|Parnaparin]]
 +
* [[Reviparin sodium|Reviparin]]
 +
* [[Tinzaparin sodium|Tinzaparin]])
  
''[[oligosaccharide]]s'' ([[Fondaparinux]], [[Idraparinux]])
+
*''[[oligosaccharide]]s'' ([[Fondaparinux]]
 +
* [[Idraparinux]])
  
''[[heparinoid]]'' ([[Danaparoid]], [[Sulodexide]], [[Dermatan sulfate]])
+
*''[[heparinoid]]'' ([[Danaparoid]]
 +
* [[Sulodexide]]
 +
* [[Dermatan sulfate]])
  
 
| group7 = [[Direct Xa inhibitor]]s
 
| group7 = [[Direct Xa inhibitor]]s
|  list7 = ''xabans'' ([[Apixaban]], [[Betrixaban]], [[Edoxaban]], [[Otamixaban]], [[Rivaroxaban]])
+
|  list7 =
 +
* ''xabans'' ([[Apixaban]]
 +
* [[Betrixaban]]
 +
* [[Edoxaban]]
 +
* [[Otamixaban]]
 +
* [[Rivaroxaban]])
  
 
}}
 
}}
  
 
| group6 = [[Direct thrombin inhibitor|Direct thrombin (II) inhibitor]]s
 
| group6 = [[Direct thrombin inhibitor|Direct thrombin (II) inhibitor]]s
|  list6 = ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]], [[Lepirudin]], [[Desirudin]])<br />
+
|  list6 =
 +
* ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]] ([[Bivalirudin]]
 +
* [[Lepirudin]]
 +
* [[Desirudin]])<br />
  
''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]&nbsp;• [[Dabigatran]]&nbsp;• [[Melagatran]]<sup>‡</sup>&nbsp;• [[Ximelagatran]]<sup>‡</sup>
+
*''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]
 +
* [[Dabigatran]]
 +
* [[Melagatran]]<sup>‡</sup>
 +
* [[Ximelagatran]]<sup>‡</sup>
  
 
| group8 = Other  
 
| group8 = Other  
|  list8 = [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]&nbsp;• [[Defibrotide]]&nbsp;• [[Ramatroban]]&nbsp;• [[Antithrombin|Antithrombin III]]&nbsp;• [[Protein C]] ([[Drotrecogin alfa]])
+
|  list8 =
 +
* [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]
 +
* [[Defibrotide]]
 +
* [[Ramatroban]]
 +
* [[Antithrombin|Antithrombin III]]
 +
* [[Protein C]] ([[Drotrecogin alfa]])
  
 
}}
 
}}
  
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 
| group5 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
|  list5 = ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]], [[Reteplase]], [[Tenecteplase]])&nbsp;• ''UPA'' ([[Urokinase]], [[Saruplase]])&nbsp;• [[Streptokinase]]<sup>#</sup>&nbsp;• [[Anistreplase]]&nbsp;• [[Monteplase]]
+
|  list5 =
 +
* ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]'' ([[Tissue plasminogen activator|Alteplase]]
 +
* [[Reteplase]]
 +
* [[Tenecteplase]])
 +
* ''UPA'' ([[Urokinase]]
 +
* [[Saruplase]])
 +
* [[Streptokinase]]<sup>#</sup>
 +
* [[Anistreplase]]
 +
* [[Monteplase]]
  
''other [[serine endopeptidase]]s:'' [[Ancrod]]&nbsp;• [[Fibrinolysin]]
+
*''other [[serine endopeptidase]]s:'' [[Ancrod]]
 
+
* [[Fibrinolysin]]
[[Brinase]]
+
* [[Brinase]]
  
  
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
 
| group8 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
|  list8 = [[Citrate]]&nbsp;• [[EDTA]]&nbsp;• [[Oxalate]]
+
|  list8 =
 +
* [[Citrate]]
 +
* [[EDTA]]
 +
* [[Oxalate]]
  
 
| group9 =  
 
| group9 =  
Line 87: Line 161:
 
}}<noinclude>
 
}}<noinclude>
 
[[Category:Antithrombotic agents]]
 
[[Category:Antithrombotic agents]]
[[Category:Drug_templates by ATC|{{PAGENAME}}]]
+
[[Category:Drug_templates by ATC]]
 
[[hu:Sablon:Antitrombotikumok]]
 
[[hu:Sablon:Antitrombotikumok]]
 
[[pt:Predefinição:Antitrombóticos]]
 
[[pt:Predefinição:Antitrombóticos]]
 
[[zh:Template:抗血栓药]]
 
[[zh:Template:抗血栓药]]
 
</noinclude>
 
</noinclude>

Revision as of 01:38, 10 February 2012